Home

Zeitplan Himmel Sympton christian steidl hummel Log Budget Delikatesse

PDF) Clinical, pathological and genetic features of primary mediastinal  large B-cell lymphomas and mediastinal gray zone lymphomas in children
PDF) Clinical, pathological and genetic features of primary mediastinal large B-cell lymphomas and mediastinal gray zone lymphomas in children

Genomic and epigenomic co-evolution in follicular lymphomas | Leukemia
Genomic and epigenomic co-evolution in follicular lymphomas | Leukemia

Tumor-Associated Macrophages and Survival in Classic Hodgkin's Lymphoma |  NEJM
Tumor-Associated Macrophages and Survival in Classic Hodgkin's Lymphoma | NEJM

Correlations between BCL6 rearrangement and outcome in patients with  diffuse large B-cell lymphoma treated with CHOP or R-CHOP | Haematologica
Correlations between BCL6 rearrangement and outcome in patients with diffuse large B-cell lymphoma treated with CHOP or R-CHOP | Haematologica

PDF) Correlations between BCL6 rearrangement and outcome in patients with  diffuse large B-cell lymphoma treated with CHOP or R-CHOP
PDF) Correlations between BCL6 rearrangement and outcome in patients with diffuse large B-cell lymphoma treated with CHOP or R-CHOP

PDF) Macrophages predict treatment outcome in Hodgkin's lymphoma
PDF) Macrophages predict treatment outcome in Hodgkin's lymphoma

Tumor-Associated Macrophages and Survival in Classic Hodgkin's Lymphoma |  NEJM
Tumor-Associated Macrophages and Survival in Classic Hodgkin's Lymphoma | NEJM

Further delineation of chromosomal consensus regions in primary mediastinal  B-cell lymphomas: an analysis of 37 tumor samples using high-resolution  genomic profiling (array-CGH) | Leukemia
Further delineation of chromosomal consensus regions in primary mediastinal B-cell lymphomas: an analysis of 37 tumor samples using high-resolution genomic profiling (array-CGH) | Leukemia

Gene expression profiling defines molecular subtypes of classical Hodgkin's  disease | Oncogene
Gene expression profiling defines molecular subtypes of classical Hodgkin's disease | Oncogene

Macrophages predict treatment outcome in Hodgkin's lymphoma | Haematologica
Macrophages predict treatment outcome in Hodgkin's lymphoma | Haematologica

Stephan MATHAS | Charité Universitätsmedizin Berlin, Berlin | Charité |  Medical Department, Division of Hematology, Oncology and Tumor Immunology
Stephan MATHAS | Charité Universitätsmedizin Berlin, Berlin | Charité | Medical Department, Division of Hematology, Oncology and Tumor Immunology

Correlations between BCL6 rearrangement and outcome in patients with  diffuse large B-cell lymphoma treated with CHOP or R-CHOP | Haematologica
Correlations between BCL6 rearrangement and outcome in patients with diffuse large B-cell lymphoma treated with CHOP or R-CHOP | Haematologica

PDF) Pharmacological restoration and therapeutic targeting of the B-cell  phenotype in classical Hodgkin lymphoma
PDF) Pharmacological restoration and therapeutic targeting of the B-cell phenotype in classical Hodgkin lymphoma

Constitutively overexpressed 21 kDa protein in Hodgkin lymphoma and  aggressive non-Hodgkin lymphomas identified as cytochrome B5b (CYB5B) |  SpringerLink
Constitutively overexpressed 21 kDa protein in Hodgkin lymphoma and aggressive non-Hodgkin lymphomas identified as cytochrome B5b (CYB5B) | SpringerLink

Hodgkin lymphoma: 2016 update on diagnosis, risk‐stratification, and  management - Ansell - 2016 - American Journal of Hematology - Wiley Online  Library
Hodgkin lymphoma: 2016 update on diagnosis, risk‐stratification, and management - Ansell - 2016 - American Journal of Hematology - Wiley Online Library

Tumor-Associated Macrophages and Survival in Classic Hodgkin's Lymphoma |  NEJM
Tumor-Associated Macrophages and Survival in Classic Hodgkin's Lymphoma | NEJM

PDF) Lymphomas with concurrent BCL2 and MYC translocations: the critical  factors associated with survival | Martin Dyer - Academia.edu
PDF) Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival | Martin Dyer - Academia.edu

Tumor-Associated Macrophages and Survival in Classic Hodgkin's Lymphoma |  NEJM
Tumor-Associated Macrophages and Survival in Classic Hodgkin's Lymphoma | NEJM

Constitutively overexpressed 21 kDa protein in Hodgkin lymphoma and  aggressive non-Hodgkin lymphomas identified as cytochrome B5b (CYB5B) |  SpringerLink
Constitutively overexpressed 21 kDa protein in Hodgkin lymphoma and aggressive non-Hodgkin lymphomas identified as cytochrome B5b (CYB5B) | SpringerLink

TP53 mutation and survival in aggressive B cell lymphoma - Zenz - 2017 -  International Journal of Cancer - Wiley Online Library
TP53 mutation and survival in aggressive B cell lymphoma - Zenz - 2017 - International Journal of Cancer - Wiley Online Library

Gunther GLEHR | Universität Regensburg, Regensburg | UR | Department of  Statistical Bioinformatics
Gunther GLEHR | Universität Regensburg, Regensburg | UR | Department of Statistical Bioinformatics

CD30 expression in de novo diffuse large B‐cell lymphoma: a  population‐based study from British Columbia - Slack - 2014 - British  Journal of Haematology - Wiley Online Library
CD30 expression in de novo diffuse large B‐cell lymphoma: a population‐based study from British Columbia - Slack - 2014 - British Journal of Haematology - Wiley Online Library

Horst HUMMEL | University of Wuerzburg, Würzburg | JMU | Department of  Internal Medicine II
Horst HUMMEL | University of Wuerzburg, Würzburg | JMU | Department of Internal Medicine II

CD30 expression in de novo diffuse large B‐cell lymphoma: a  population‐based study from British Columbia - Slack - 2014 - British  Journal of Haematology - Wiley Online Library
CD30 expression in de novo diffuse large B‐cell lymphoma: a population‐based study from British Columbia - Slack - 2014 - British Journal of Haematology - Wiley Online Library

TP53 mutation and survival in aggressive B cell lymphoma - Zenz - 2017 -  International Journal of Cancer - Wiley Online Library
TP53 mutation and survival in aggressive B cell lymphoma - Zenz - 2017 - International Journal of Cancer - Wiley Online Library

Constitutively overexpressed 21 kDa protein in Hodgkin lymphoma and  aggressive non-Hodgkin lymphomas identified as cytochrome B5b (CYB5B) |  SpringerLink
Constitutively overexpressed 21 kDa protein in Hodgkin lymphoma and aggressive non-Hodgkin lymphomas identified as cytochrome B5b (CYB5B) | SpringerLink